Media Statements

  1. Home
  2. Media Statements
April 20, 2020
in Media Statements

Statement by Bayer on Motions to Intervene in Cases Brought Against the Environmental Protection Agency on Glyphosate Registration

Bayer issued the following statement today in response to motions to intervene filed in Rural Coalition et al. v. U.S. Environmental Protection Agency et al. and a parallel case brought by the Natural Resources Defense Council, cases which challenge EPA’s Interim Registration Review Decision on glyphosate. Monsanto filed this motion and this one alongside 10 associations, which represent a substantial segment of U.S. agriculture and other professions that utilize and rely on glyphosate, and these parties have jointly requested to intervene in support of the EPA in these cases before the U.S. Ninth Circuit Court of Appeals.

Continue reading
April 2, 2020
in Media Statements

Bayer Statement on Mediation in the Roundup Litigation

“We’ve made progress in the Roundup mediation discussions, but the COVID-19 dynamics, including restrictions imposed in recent weeks, have caused meeting cancellations and delayed this process as Ken Feinberg noted, much as they have for many business activities, U.S. court proceedings and more. As a result, the mediation process has significantly slowed, and realistically, we […]

Continue reading
February 10, 2020
in Media Statements

Monsanto Urges California Appeals Court to Reverse Verdict in Pilliod Glyphosate Case

Opening Brief Argues Preemption, Lack of Evidence to Support Liability, Causation and Punitive Damages, Failure to Sever Cases, Admission of Irrelevant and Prejudicial Evidence, and Pervasive Misconduct by Plaintiffs’ Counsel Whippany, N.J., February 10, 2020 – In its opening appeal brief, Monsanto urged the California Court of Appeal to reverse the verdict in Pilliod v. Monsanto because […]

Continue reading
January 31, 2020
in Media Statements

Bayer Welcomes U.S. Environmental Protection Agency’s Reaffirmation that Glyphosate Is Safe to Use, Not Carcinogenic

EPA’s Interim Registration Review Decision Follows Agency Letter to Registrants and the U.S. Government’s Amicus Filing in Hardeman Case That Also Support Glyphosate’s Safety Whippany, N.J., January 31, 2020 – Bayer said today that the U.S. Environmental Protection Agency’s favorable conclusion about the safety of glyphosate in its Interim Registration Review Decision, based on the agency’s […]

Continue reading
December 23, 2019
in Media Statements

U.S. Government, 7 States Among 16 Parties To File Amicus Briefs In Monsanto’s Hardeman Appeal

WHIPPANY, N.J., December 23, 2019 –Bayer said today that six amicus briefs were filed in its appeal of the Hardeman case before the Ninth Circuit Court of Appeals, representing 16 public, professional, trade and commercial entities. The briefs make arguments on a range of issues including federal preemption, Daubert standards, and the admissibility of expert […]

Continue reading
July 25, 2019
in Media Statements

Bayer Statement on Post-Trial Ruling in Pilliod v. Monsanto

Whippany (July 25, 2019) — The following is Bayer’s statement regarding a ruling in Pilliod v. Monsanto by Judge Winifred Smith in the Superior Court of the State of California for the County of Alameda to reduce the punitive, non- economic, and future medical damages in the case. The court reduced Mr. Pilliod’s non-economic damages from $18 million to $6.1 million and […]

Continue reading

Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.

Read about the five-point plan here.